应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LEGN 传奇生物
休市中 11-13 16:00:00 EST
17.50
-1.04
-5.61%
盘后
17.50
+0.00
0.00%
19:30 EST
最高
18.61
最低
17.39
成交量
302.99万
今开
18.46
昨收
18.54
日振幅
6.61%
总市值
34.04亿
流通市值
16.02亿
总股本
1.94亿
成交额
5,382万
换手率
3.31%
流通股本
9,154万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|传奇生物盘中下跌5.37%,财报后目标价再遭下调
行情直击 · 04:30
异动解读|传奇生物盘中下跌5.37%,财报后目标价再遭下调
异动解读|传奇生物盘中下跌5.02%,财报后机构下调目标价
行情直击 · 11-13 04:02
异动解读|传奇生物盘中下跌5.02%,财报后机构下调目标价
传奇生物(LEGN)三季度净利润5170万美元 同比扭亏为盈
金吾财讯 · 11-10
传奇生物(LEGN)三季度净利润5170万美元 同比扭亏为盈
金斯瑞生物科技:联营公司传奇生物发布截至2026年三季度财务业绩
南方财经网 · 11-10
金斯瑞生物科技:联营公司传奇生物发布截至2026年三季度财务业绩
财报前瞻 | 传奇生物本季度营收预计增长32.71%,机构观点偏正面
财报Agent · 11-03
财报前瞻 | 传奇生物本季度营收预计增长32.71%,机构观点偏正面
只要优秀,招聘人数不设限!
同花顺 · 11-02
只要优秀,招聘人数不设限!
核心单品销售再获业绩验证,传奇生物(LEGN.US)何时扭转股价“短强中弱”结构
智通财经 · 10-15
核心单品销售再获业绩验证,传奇生物(LEGN.US)何时扭转股价“短强中弱”结构
金斯瑞生物科技:传奇生物核心产品第三季度贸易销售净额约7.1亿美元
南方财经网 · 10-13
金斯瑞生物科技:传奇生物核心产品第三季度贸易销售净额约7.1亿美元
传奇生物:Huang Ying拟出售6.98万股,市值约130.21万美元
南方财经网 · 09-23
传奇生物:Huang Ying拟出售6.98万股,市值约130.21万美元
诺华前中国总裁张颖加盟传奇生物,担任首席执行官
智通财经 · 09-15
诺华前中国总裁张颖加盟传奇生物,担任首席执行官
历经多重利空2个月股价腰斩,传奇生物(LEGN.US)挖出估值陷阱还是黄金坑?
智通财经 · 08-11
历经多重利空2个月股价腰斩,传奇生物(LEGN.US)挖出估值陷阱还是黄金坑?
中概股龙头指数盘初上涨0.75%
每日经济新闻 · 08-07
中概股龙头指数盘初上涨0.75%
财报前瞻|传奇生物本季度营收预计增55.36%,机构观点偏正面
财报Agent · 08-04
财报前瞻|传奇生物本季度营收预计增55.36%,机构观点偏正面
*ST集友拟斥资10.06亿元收购慧聚药业50.76%股权;传奇生物首席执行官黄颖辞职|医药早参
每日经济新闻 · 07-28
*ST集友拟斥资10.06亿元收购慧聚药业50.76%股权;传奇生物首席执行官黄颖辞职|医药早参
暗流涌动:传奇生物CEO突然离职,股价重挫
投资观察 · 07-28
暗流涌动:传奇生物CEO突然离职,股价重挫
传奇生物盘前下跌3.7%;黄颖辞任CEO及董事,Alan Bash被任命为临时CEO
美股速递 · 07-27
传奇生物盘前下跌3.7%;黄颖辞任CEO及董事,Alan Bash被任命为临时CEO
传奇生物盘前下跌 3.7%;黄颖卸任首席执行官及董事,Alan Bash 出任临时 CEO。
智通财经 · 07-27
传奇生物盘前下跌 3.7%;黄颖卸任首席执行官及董事,Alan Bash 出任临时 CEO。
传奇生物CEO黄颖辞职,留任顾问至八月
美股速递 · 07-27
传奇生物CEO黄颖辞职,留任顾问至八月
传奇生物CAR-T疗法第二季度产生贸易销售净额约6.57亿美元;天智航筹划购买上海骨科控股权 | 医药早参
每日经济新闻 · 07-16
传奇生物CAR-T疗法第二季度产生贸易销售净额约6.57亿美元;天智航筹划购买上海骨科控股权 | 医药早参
传奇生物:Carvykti®在截至2026年6月30日的季度实现约6.57亿美元净贸易销售额
美股速递 · 07-15
传奇生物:Carvykti®在截至2026年6月30日的季度实现约6.57亿美元净贸易销售额
公司概况
公司名称:
传奇生物
所属市场:
NASDAQ
上市日期:
--
主营业务:
传奇生物科技有限公司是一家全球性的临床级生物制药公司,致力于肿瘤和其他适应症的新药的发现和开发。该公司的差异化技术、全球开发和制造战略及专业知识使其能够针对高未满足需求的适应症生成、测试和制造下一代细胞疗法。
发行价格:
--
{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"传奇生物","latestPrice":17.5,"timestamp":1794603600000,"preClose":18.54,"halted":0,"volume":3029910,"hourTrading":{"tag":"盘后","latestPrice":17.5,"preClose":17.5,"latestTime":"19:30 EST","volume":52200,"amount":913526.6015,"timestamp":1794616201784,"change":0,"changeRate":0,"amplitude":0.003429},"delay":0,"changeRate":-0.0560949298813376,"floatShares":91540800,"shares":194488413,"eps":-0.012146,"marketStatus":"休市中","change":-1.04,"latestTime":"11-13 16:00:00 EST","open":18.46,"high":18.61,"low":17.385,"amount":53823493.94487,"amplitude":0.066073,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.012146,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":18.54,"preHourTrading":{"tag":"盘前","latestPrice":18.6,"preClose":18.54,"latestTime":"09:25 EST","volume":829,"amount":15428.729566,"timestamp":1794579900008,"change":0.06,"changeRate":0.003236,"amplitude":0.053937},"postHourTrading":{"tag":"盘后","latestPrice":17.5,"preClose":17.5,"latestTime":"19:30 EST","volume":52200,"amount":913526.6015,"timestamp":1794616201784,"change":0,"changeRate":0,"amplitude":0.003429},"volumeRatio":0.795043,"impliedVol":0.8976,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/LEGN/wiki","defaultTab":"wiki","newsList":[{"id":"1191108662","title":"异动解读|传奇生物盘中下跌5.37%,财报后目标价再遭下调","url":"https://stock-news.laohu8.com/highlight/detail?id=1191108662","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191108662?lang=zh_cn&edition=full","pubTime":"2026-11-14 04:30","pubTimestamp":1794601853,"startTime":"0","endTime":"0","summary":"11月14日,传奇生物盘中下跌5.37%,报17.545美元/股,成交额4016.52万美元。此次走弱的直接催化,来自公司三季报发布后卖方机构持续下调目标价。最新消息显示,Evercore ISI将公司评级下调至In Line;此前RBC将目标价降至50美元,Morgan Stanley降至43美元,Oppenheimer降至25美元,Barclays也降至61美元。传奇生物科技有限公司是一家全球性的临床级生物制药公司,致力于肿瘤和其他适应症的新药的发现和开发。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报后遭机构下调目标价,传奇生物盘中走弱","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127607130","title":"异动解读|传奇生物盘中下跌5.02%,财报后机构下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1127607130","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127607130?lang=zh_cn&edition=full","pubTime":"2026-11-13 04:02","pubTimestamp":1794513774,"startTime":"0","endTime":"0","summary":"11月13日,传奇生物盘中下跌5.02%,报18.56美元/股,成交额6685.46万美元。消息面上,公司三季度虽实现净利润5170万美元、CARVYKTI净销售额同比增长36%至约7.1亿美元,但营收3.595亿美元略低于市场预期,财报后多家机构下调目标价,其中RBC将目标价降至50美元并维持跑赢大市,Morgan Stanley降至43美元,Oppenheimer降至25美元。传奇生物科技有限公司是一家全球性的临床级生物制药公司,致力于肿瘤和其他适应症的新药的发现和开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"传奇生物盘中下挫,机构下调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682318517","title":"传奇生物(LEGN)三季度净利润5170万美元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2682318517","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682318517?lang=zh_cn&edition=full","pubTime":"2026-11-10 21:04","pubTimestamp":1794315868,"startTime":"0","endTime":"0","summary":"金吾财讯 | 传奇生物 公布2026年第三季度财报。数据显示,三季度净利润达5170万美元,而去年同期为亏损3960万美元,同比扭亏为盈;稀释每股收益为0.13美元。CARVYKTI净销售额同比增长36%,达到约7.1亿美元。前三季度,公司总收入为10.521亿美元,高于去年同期的7.225亿美元;净利润为3060万美元,扭转了上年同期的2.660亿美元亏损。研发费用降至2.770亿美元,管理费用降至8780万美元。截至2026年9月30日,现金、现金等价物及定期存款余额约为8.53亿美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MGE2ZWRkM2ExNzliODFiMWYxODE0Mjk1MTc3MTQ2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGE2ZWRkM2ExNzliODFiMWYxODE0Mjk1MTc3MTQ2.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"308192","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682390946","title":"金斯瑞生物科技:联营公司传奇生物发布截至2026年三季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2682390946","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682390946?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:49","pubTimestamp":1794314962,"startTime":"0","endTime":"0","summary":"21财经11月10日电,金斯瑞生物科技(01548.HK)发布自愿公告,公司联营公司传奇生物科技股份有限公司已向美国证券交易委员会提交相关表格,披露截至2026年9月30日止第三季度的财务业绩及近期业务亮点。上述财务业绩仅针对传奇生物,而非本公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611103927527475.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611103927527475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","MEMS","MEDI","BK4588","BK4139","BK4505","LEGN","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135721658","title":"财报前瞻 | 传奇生物本季度营收预计增长32.71%,机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1135721658","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135721658?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:27","pubTimestamp":1793665677,"startTime":"0","endTime":"0","summary":"传奇生物将于2026年11月10日发布最新季度财报,市场关注CAR-T商业化放量、合资与许可合作进展对收入和利润的边际改善。上季度营收3.88亿美元,同比增加51.93%;毛利率64.54%;归属于母公司的净利润为3,320.00万美元,净利率8.57%;调整后每股收益为0.18美元,同比上升126.47%。若按市场对本季度营收3.62亿美元、同比增长32.71%的预期测算,协作收入将继续维持高权重,预计仍是主要的边际贡献来源。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 传奇生物本季度营收预计增长32.71%,机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2680200970","title":"只要优秀,招聘人数不设限!","url":"https://stock-news.laohu8.com/highlight/detail?id=2680200970","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680200970?lang=zh_cn&edition=full","pubTime":"2026-11-02 04:55","pubTimestamp":1793566500,"startTime":"0","endTime":"0","summary":"□ 本报记者黄红芳11月1日,南京国际博览中心人头攒动,2026首届南京人才周暨第十八届中国留学人员南京国际交流与合作大会在这里拉开帷幕,2000家用人单位携3万个优质岗位现场招聘,吸引了 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261102/c681330452.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261102/c681330452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDI","MEMS","BK4588","CANC","BK4139","BK4505","LEGN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675538442","title":"核心单品销售再获业绩验证,传奇生物(LEGN.US)何时扭转股价“短强中弱”结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2675538442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675538442?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:06","pubTimestamp":1792073162,"startTime":"0","endTime":"0","summary":"10月13日,强生披露其26Q3季度财报。然而,上述强劲的销售数据却未带来传奇生物股价的显著反弹。与此同时,公司股价在当日同时站上站上5日、10日和20日均线,且出现了MACD和KDJ指标金叉。此时,传奇生物股价在日线级别的短线转强已十分明确。不过,消息面刺激下的单日资金回流仍难以支撑传奇生物股价后续的趋势反转。若该品种顺利获批,BCMA CAR-T全球赛道将正式形成 CARVYKTI、Abecma、anito-cel 三强竞争格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","CANC","BK4585","MEDI","LEGN","MEMS","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675354717","title":"金斯瑞生物科技:传奇生物核心产品第三季度贸易销售净额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675354717","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675354717?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:33","pubTimestamp":1791894780,"startTime":"0","endTime":"0","summary":"南财智讯10月13日电,金斯瑞生物科技(01548.HK)发布自愿公告,公司联营公司传奇生物已向美国证券交易委员会提交相关表格,宣布根据传奇与杨森订立的合作及许可协议,核心产品西达基奥仑赛于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元。贸易销售净额乃基于杨森向传奇提供的资料,传奇与公司均未独立核实该销售数字的准确性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610133894345938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610133894345938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000306701.USD","BK4139","MEMS","BK4585","BK4588","HK0000320264.USD","LEGN","HK0000306685.HKD","BK1583","HK0000320223.HKD","BK4505","01548","MEDI","BK1141","BK1576","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669200411","title":"传奇生物:Huang Ying拟出售6.98万股,市值约130.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669200411","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669200411?lang=zh_cn&edition=full","pubTime":"2026-09-23 06:42","pubTimestamp":1790116920,"startTime":"0","endTime":"0","summary":"南财智讯9月23日电,传奇生物(LegendBiotechCorp,纳斯达克:LEGN)前高管兼董事HuangYing提交Form144限制股出售声明。HuangYing拟出售69812股美国存托股份(ADS),合计市值约130.21万美元,拟出售日期为9月22日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609233881653835.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609233881653835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","MEDI","BK4588","CANC","BK4505","LEGN","MEMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667822647","title":"诺华前中国总裁张颖加盟传奇生物,担任首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2667822647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667822647?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:43","pubTimestamp":1789476228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","MEDX","IE00BJJMRZ35.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4007","BK4585","BK4532","MEDI","IE00B2B36J28.USD","LU0320765489.SGD","IE0002141913.USD","LEGN","CANC","MEMS","IE00BFTCPJ56.SGD","BK4588","BK4505","LU0208291251.USD","BK4139","NVS","PPH","LU0070302665.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997199","title":"历经多重利空2个月股价腰斩,传奇生物(LEGN.US)挖出估值陷阱还是黄金坑?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658997199?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:05","pubTimestamp":1786442705,"startTime":"0","endTime":"0","summary":"在历经2个月将股价拉回37.50美元高点后,传奇生物再用了2个月将股价跌回了20美元以下的起点,回吐了4月和5月的全部股价涨幅。去年在12月初,在传奇生物股价彼时开始反弹冲刺之际,来自合作伙伴强生的一记暴击便打在了传奇生物的命门上。并且对比Carvykti在34个月的随访数据,Tec-Dara联合治疗组已经超越其的84.6%响应率和76.4%的OS率,且在残余病灶阴性率上与Carvykti保持一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UYM","518880","IAUI","AAAU","GDXY","GDXD","GLTR","USG","PALL","MGCmain","GDXJ","PICK","OUNZ","159831","JNUG","FGDL","BAR","DGP","QOmain","GDXU","GOAU","GLDM","MEDI","CEF","SGDM","GDX","IAUM","JDST","NUGT","BEGS","DZZ","SGCmain","SHNY","PHYS","XME","UGL","FAAR","DULL","LEGN","RING","GLL","IAU","SGOL","GOLY","DBC","1OZmain","BTGD","GCmain","DUST","GBUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564189","title":"中概股龙头指数盘初上涨0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564189","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657564189?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:32","pubTimestamp":1786109554,"startTime":"0","endTime":"0","summary":"8月7日,利弗莫尔中概股龙头指数盘初上涨0.75%。成分股中,希尔威金属矿业涨8.34%,百济神州涨5.85%,禾赛涨5.38%,奇景光电涨4.87%,传奇生物涨4.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835476887.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835476887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HSAI","BK4141","SVM","LU2778985437.USD","LU2476274308.USD","CANC","BK4588","BK4139","BK4210","SLVR","BK4585","LU2476274720.SGD","02525","ONC","MEMS","SLVX","MEDI","BK4526","06160","BK4124","HIMX","BK4505","LEGN","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147859893","title":"财报前瞻|传奇生物本季度营收预计增55.36%,机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1147859893","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147859893?lang=zh_cn&edition=full","pubTime":"2026-08-04 08:48","pubTimestamp":1785804491,"startTime":"0","endTime":"0","summary":"传奇生物将于2026年08月11日发布财报,市场聚焦核心产品商业化推进与合作收入节奏变化对本季度盈利弹性的影响。市场一致预期显示,本季度营收预计为3.56亿美元,同比增55.36%;预计EBIT为3,122.53万美元,同比增172.82%;预计每股收益为0.08美元,同比增152.37%。若公司在上一季度财报中提供了对本季度的毛利率或净利率、调整后每股收益等预测,则以公司口径为准;目前未检索到公司口径的本季度毛利率、净利率与调整后每股收益的明确数值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|传奇生物本季度营收预计增55.36%,机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2654035026","title":"*ST集友拟斥资10.06亿元收购慧聚药业50.76%股权;传奇生物首席执行官黄颖辞职|医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2654035026","media":"每日经济新闻","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654035026?lang=zh_cn&edition=full","pubTime":"2026-07-28 07:01","pubTimestamp":1785193286,"startTime":"0","endTime":"0","summary":"丨2026年7月28日星期二丨NO.1石药创新:预计上半年盈利11.8亿元~13.6亿元,同比扭亏石药创新披露业绩预告,预计2026年上半年归母净利润11.8亿元~13.6亿元,同比扭亏为盈,上年同期亏损274.61万元。报告期内,公司生物制药业务研发成果持续兑现。控股子公司巨石生物与阿斯利康签署《战略合作与授权协议》,将与阿斯利康在创新多肽分子药物领域开展合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283822543016.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283822543016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0132","BK4585","09939","BK1574","MEDI","BK4588","BK0263","CANC","603429","159938","BK1515","BK4505","LEGN","MEMS","BK4139","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166809875","title":"暗流涌动:传奇生物CEO突然离职,股价重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1166809875","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166809875?lang=zh_cn&edition=full","pubTime":"2026-07-28 01:02","pubTimestamp":1785171772,"startTime":"0","endTime":"0","summary":"传奇生物股价周一暴跌14%,此前公司宣布首席执行官黄颖已辞职并退出董事会。传奇生物在一份监管文件中表示,黄颖的辞职并非因与公司存在分歧,但并未就离职原因给出更多细节。黄颖暂未回应置评请求。董事会已任命负责公司主要药物业务部门的总裁Alan Bash为临时首席执行官,同时着手物色正式继任者。在周一传出黄颖离职的消息之前,传奇生物股价自本月以来已累计下跌23%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MEMS","BK4588","LEGN","CANC","BK4505","BK4585","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149183951","title":"传奇生物盘前下跌3.7%;黄颖辞任CEO及董事,Alan Bash被任命为临时CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1149183951","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149183951?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:22","pubTimestamp":1785147766,"startTime":"0","endTime":"0","summary":"传奇生物(Legend Biotech)盘前股价下跌3.7%。公司宣布,黄颖(Ying Huang)已辞去首席执行官及董事会成员职务。与此同时,Alan Bash被任命为临时CEO,接替其工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LEGN","BK4505","MEMS","MEDI","BK4139","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654019214","title":"传奇生物盘前下跌 3.7%;黄颖卸任首席执行官及董事,Alan Bash 出任临时 CEO。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654019214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654019214?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:22","pubTimestamp":1785147758,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","CANC","LEGN","MEDI","MEMS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115533527","title":"传奇生物CEO黄颖辞职,留任顾问至八月","url":"https://stock-news.laohu8.com/highlight/detail?id=1115533527","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115533527?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:01","pubTimestamp":1785146471,"startTime":"0","endTime":"0","summary":"传奇生物(Legend Biotech Corp)今日宣布,黄颖(Ying Huang)正式辞去首席执行官及董事会成员职务。但他并未就此彻底离开——黄颖将以顾问身份继续为公司服务,直至今年八月。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","BK4505","CANC","BK4588","BK4139","LEGN","BK4585","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651491248","title":"传奇生物CAR-T疗法第二季度产生贸易销售净额约6.57亿美元;天智航筹划购买上海骨科控股权 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2651491248","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651491248?lang=zh_cn&edition=full","pubTime":"2026-07-16 07:04","pubTimestamp":1784156682,"startTime":"0","endTime":"0","summary":"丨2026年7月16日星期四丨NO.1天智航筹划发行股份购买上海骨科的控股权并募集配套资金7月15日,天智航公告称,公司正在筹划以发行股份的方式购买上海微创骨科医疗科技有限公司(简称“上海骨科”)的控股权,同时拟募集配套资金。根据上海证券交易所相关规定,经公司申请,公司股票将于2026年7月16日(星期四)开市起停牌,预计停牌时间不超过5个交易日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607163807947018.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607163807947018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4230","LEGN","09939","159938","BK4585","BK4588","BK4505","MEMS","CAR","MEDI","BK1161","BK4022","CANC","BK1515","BK1574","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156679331","title":"传奇生物:Carvykti®在截至2026年6月30日的季度实现约6.57亿美元净贸易销售额","url":"https://stock-news.laohu8.com/highlight/detail?id=1156679331","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156679331?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:33","pubTimestamp":1784115202,"startTime":"0","endTime":"0","summary":"传奇生物宣布,其核心产品Carvykti®在截至2026年6月30日的季度中,录得约6.57亿美元的净贸易销售额。这一业绩凸显了该细胞疗法强劲的商业化势头和市场接受度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","MEMS","BK4585","LEGN","CANC","BK4588","BK4139","MEDI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":-0.2521},{"period":"1month","weight":-0.0809},{"period":"3month","weight":-0.1409},{"period":"6month","weight":-0.3648},{"period":"1year","weight":-0.4357},{"period":"ytd","weight":-0.195}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"传奇生物科技有限公司是一家全球性的临床级生物制药公司,致力于肿瘤和其他适应症的新药的发现和开发。该公司的差异化技术、全球开发和制造战略及专业知识使其能够针对高未满足需求的适应症生成、测试和制造下一代细胞疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.047546},{"month":2,"riseRate":0.5,"avgChangeRate":0.01776},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.03136},{"month":4,"riseRate":0.833333,"avgChangeRate":0.112839},{"month":5,"riseRate":0.5,"avgChangeRate":0.032168},{"month":6,"riseRate":1,"avgChangeRate":0.13586},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.022064},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.03044},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026101},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012287},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.045201},{"month":12,"riseRate":0,"avgChangeRate":-0.105244}],"exchange":"NASDAQ","name":"传奇生物","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"传奇生物,LEGN,传奇生物股票,传奇生物股票老虎,传奇生物股票老虎国际,传奇生物行情,传奇生物股票行情,传奇生物股价,传奇生物股市,传奇生物股票价格,传奇生物股票交易,传奇生物股票购买,传奇生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}